查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
多重檢測市場：按產品類型、應用和最終用戶：2023-2032 年全球機會分析和產業預測
市場調查報告書
商品編碼
1414723

多重檢測市場：按產品類型、應用和最終用戶：2023-2032 年全球機會分析和產業預測

Multiplex Assay Market By Type, By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 430 Pages | 商品交期: 2-3個工作天內

價格

2022 年多重檢測市場規模為 36 億美元，預計 2023 年至 2032 年複合年成長率為 7.8%，到 2032 年將達到 77 億美元。

多重測定是一種實驗技術，可讓研究人員同時測量一個生物樣本中的多種分析物（例如蛋白質、核酸或其他分子）。這種方法在科學和醫學的許多領域都很有價值，包括基因組學、蛋白質組學、免疫學和臨床診斷，因為它可以在單一實驗中對多個參數進行高效且經濟有效的評估。

多重檢測市場-IMG1

然而，高資本投資和技術純熟勞工短缺是限制多重檢測市場成長的主要因素。此外，高昂的採購和營運成本以及多重偵測設備的繁瑣和複雜性是多重偵測市場的主要障礙。此外，分子和蛋白質診斷中生物標記的日益檢驗以及對高通量和自動化系統不斷成長的需求預計將為未來的全球市場擴張創造有利的機會。此外，臨床研究和藥物研發資金籌措的增加預計將進一步推動多重市場的成長。

多重檢測市場按類型、產品、應用、最終用戶和地區進行細分。根據類型，它們可以分為基於蛋白質的多重檢測、基於核酸的多重檢測和基於細胞的多重檢測。從產品的角度來看，市場分為試劑和消耗品、設備和配件以及軟體和服務。根據應用，多重檢測市場分為臨床診斷、研究和開發以及伴同性診斷。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 慢性病增加
      • 個體化藥物的採用增加
      • 連接複用產品的技術進步
    • 抑制因素
      • 缺乏技術純熟勞工/醫療保健專業人員
    • 機會
      • 活性化研發活動

第4章多重檢測市場：依類型

  • 概述
  • 基於蛋白質的多重檢測
  • 基於核酸的多重檢測
  • 基於細胞的多重檢測

第5章多重檢測市場：依產品

  • 概述
  • 試劑/耗材
  • 設備/配件
  • 軟體和服務

第6章多重檢測市場：依應用分類

  • 概述
  • 臨床診斷
  • 研究與開發
  • 伴同性診斷劑

第7章多重檢測市場：依最終用戶分類

  • 概述
  • 醫院
  • 臨床實驗室
  • 研究機構
  • 製藥和生物技術公司

第8章多重檢測市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 澳洲
    • 印度
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第9章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第10章 公司簡介

  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Randox Laboratories Limited
  • Bio-Rad Laboratories, Inc.
  • Abcam plc.
  • Qiagen NV
  • Becton, Dickinson and Company
  • Seegene Inc
  • MESO SCALE DIAGNOSTICS, LLC
  • Diasorin SpA
Product Code: A01591

According to a new report published by Allied Market Research, titled, "Multiplex Assay Market," The multiplex assay market was valued at $3.6 billion in 2022, and is estimated to reach $7.7 billion by 2032, growing at a CAGR of 7.8% from 2023 to 2032. A multiplex assay is a laboratory technique that allows researchers to simultaneously measure multiple analytes (such as proteins, nucleic acids, or other molecules) in a single biological sample. This method is valuable in various fields of science and medicine, including genomics, proteomics, immunology, and clinical diagnostics, as it enables the efficient and cost-effective assessment of multiple parameters in a single experiment.

Multiplex Assay Market - IMG1

However, high capital investments and dearth of skilled labors are the major factors that are expected to restrict the growth of the multiplex assay market. The high procurement and operational costs along with cumbersome and complex nature of multiplex assay instruments remain a key hurdle in the multiplex assay market. Moreover, increase in validation of biomarkers in molecular and protein diagnostics, along with rise in need of high-throughput and automated systems are anticipated to create lucrative opportunities for the expansion of the global market in the future. In addition, increase in funding for clinical research and drug discovery are expected to further propel the multiplex market growth.

The multiplex assay market is segmented on the basis of type, product, application, end user, and region. On the basis of type, the market is divided into protein based multiplex assay, nucleic acid-based multiplex assay, and cell-based multiplex assays. On the basis of product, the market is classified into reagents & consumables, instruments & accessories, and software & services. On the basis of application, the multiplex assay market is segregated into clinical diagnostics, research and development, and companion diagnostics.

On the basis of end user, the market is segregated into hospitals, clinical laboratories, research institutes, and pharmaceuticals & biotechnology companies. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major players profiled in the report are Abcam plc, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., DiaSorin S.p.A. (Luminex Corporation), Illumina Inc., Meso Scale Diagnostics LLC, QIAGEN N.V., Randox Laboratories Ltd., Seegene Inc., Thermo Fisher Scientific Inc. These major players have adopted acquisition, agreement, expansion, partnership, product launch, product approval as key developmental strategy to improve the product portfolio of the multiplex assay market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the multiplex assay market analysis from 2022 to 2032 to identify the prevailing multiplex assay market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the multiplex assay market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global multiplex assay market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Go To Market Strategy
  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Additional company profiles with specific to client's interest
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By End User

  • Hospitals
  • Clinical Laboratories
  • Research Institutes
  • Pharmaceutical and Biotechnology Companies

By Type

  • Protein Based Multiplex Assays
  • Nucleic Acid-Based Multiplex Assays
  • Cell-based Multiplex Assays

By Product

  • Reagents and Consumables
  • Instruments and Accessories
  • Software and Services

By Application

  • Companion Diagnostics
  • Clinical Diagnostics
  • Research and Development

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Randox Laboratories Limited
    • Qiagen N.V
    • Seegene Inc
    • Thermo Fisher Scientific Inc.
    • Illumina Inc.
    • Bio-Rad Laboratories, Inc.
    • Abcam plc.
    • Becton, Dickinson and Company
    • MESO SCALE DIAGNOSTICS, LLC
    • Diasorin S.p.A.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of chronic disease
      • 3.4.1.2. Rise in adoption of personalized medicines
      • 3.4.1.3. Technological advancements in multiplexed products
    • 3.4.2. Restraints
      • 3.4.2.1. Lack of skilled labor/healthcare professionals
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise in R&D activities

CHAPTER 4: MULTIPLEX ASSAY MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Protein Based Multiplex Assays
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Nucleic Acid-Based Multiplex Assays
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Cell-based Multiplex Assays
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: MULTIPLEX ASSAY MARKET, BY PRODUCT

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Reagents and Consumables
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Instruments and Accessories
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Software and Services
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: MULTIPLEX ASSAY MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Clinical Diagnostics
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Research and Development
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Companion Diagnostics
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: MULTIPLEX ASSAY MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Hospitals
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Clinical Laboratories
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Research Institutes
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country
  • 7.5. Pharmaceutical and Biotechnology Companies
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by region
    • 7.5.3. Market share analysis by country

CHAPTER 8: MULTIPLEX ASSAY MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by Type
    • 8.2.3. Market size and forecast, by Product
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Market size and forecast, by Type
      • 8.2.6.1.2. Market size and forecast, by Product
      • 8.2.6.1.3. Market size and forecast, by Application
      • 8.2.6.1.4. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Market size and forecast, by Type
      • 8.2.6.2.2. Market size and forecast, by Product
      • 8.2.6.2.3. Market size and forecast, by Application
      • 8.2.6.2.4. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Market size and forecast, by Type
      • 8.2.6.3.2. Market size and forecast, by Product
      • 8.2.6.3.3. Market size and forecast, by Application
      • 8.2.6.3.4. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by Type
    • 8.3.3. Market size and forecast, by Product
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Market size and forecast, by Type
      • 8.3.6.1.2. Market size and forecast, by Product
      • 8.3.6.1.3. Market size and forecast, by Application
      • 8.3.6.1.4. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Market size and forecast, by Type
      • 8.3.6.2.2. Market size and forecast, by Product
      • 8.3.6.2.3. Market size and forecast, by Application
      • 8.3.6.2.4. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Market size and forecast, by Type
      • 8.3.6.3.2. Market size and forecast, by Product
      • 8.3.6.3.3. Market size and forecast, by Application
      • 8.3.6.3.4. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Market size and forecast, by Type
      • 8.3.6.4.2. Market size and forecast, by Product
      • 8.3.6.4.3. Market size and forecast, by Application
      • 8.3.6.4.4. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Market size and forecast, by Type
      • 8.3.6.5.2. Market size and forecast, by Product
      • 8.3.6.5.3. Market size and forecast, by Application
      • 8.3.6.5.4. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Market size and forecast, by Type
      • 8.3.6.6.2. Market size and forecast, by Product
      • 8.3.6.6.3. Market size and forecast, by Application
      • 8.3.6.6.4. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by Type
    • 8.4.3. Market size and forecast, by Product
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Market size and forecast, by Type
      • 8.4.6.1.2. Market size and forecast, by Product
      • 8.4.6.1.3. Market size and forecast, by Application
      • 8.4.6.1.4. Market size and forecast, by End User
      • 8.4.6.2. China
      • 8.4.6.2.1. Market size and forecast, by Type
      • 8.4.6.2.2. Market size and forecast, by Product
      • 8.4.6.2.3. Market size and forecast, by Application
      • 8.4.6.2.4. Market size and forecast, by End User
      • 8.4.6.3. Australia
      • 8.4.6.3.1. Market size and forecast, by Type
      • 8.4.6.3.2. Market size and forecast, by Product
      • 8.4.6.3.3. Market size and forecast, by Application
      • 8.4.6.3.4. Market size and forecast, by End User
      • 8.4.6.4. India
      • 8.4.6.4.1. Market size and forecast, by Type
      • 8.4.6.4.2. Market size and forecast, by Product
      • 8.4.6.4.3. Market size and forecast, by Application
      • 8.4.6.4.4. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Market size and forecast, by Type
      • 8.4.6.5.2. Market size and forecast, by Product
      • 8.4.6.5.3. Market size and forecast, by Application
      • 8.4.6.5.4. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Market size and forecast, by Type
      • 8.4.6.6.2. Market size and forecast, by Product
      • 8.4.6.6.3. Market size and forecast, by Application
      • 8.4.6.6.4. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by Type
    • 8.5.3. Market size and forecast, by Product
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Market size and forecast, by Type
      • 8.5.6.1.2. Market size and forecast, by Product
      • 8.5.6.1.3. Market size and forecast, by Application
      • 8.5.6.1.4. Market size and forecast, by End User
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Market size and forecast, by Type
      • 8.5.6.2.2. Market size and forecast, by Product
      • 8.5.6.2.3. Market size and forecast, by Application
      • 8.5.6.2.4. Market size and forecast, by End User
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Market size and forecast, by Type
      • 8.5.6.3.2. Market size and forecast, by Product
      • 8.5.6.3.3. Market size and forecast, by Application
      • 8.5.6.3.4. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Market size and forecast, by Type
      • 8.5.6.4.2. Market size and forecast, by Product
      • 8.5.6.4.3. Market size and forecast, by Application
      • 8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product mapping of top 10 player
  • 9.4. Competitive dashboard
  • 9.5. Competitive heatmap
  • 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

  • 10.1. Thermo Fisher Scientific Inc.
    • 10.1.1. Company overview
    • 10.1.2. Key executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
  • 10.2. Illumina Inc.
    • 10.2.1. Company overview
    • 10.2.2. Key executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
  • 10.3. Randox Laboratories Limited
    • 10.3.1. Company overview
    • 10.3.2. Key executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
  • 10.4. Bio-Rad Laboratories, Inc.
    • 10.4.1. Company overview
    • 10.4.2. Key executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Business performance
    • 10.4.7. Key strategic moves and developments
  • 10.5. Abcam plc.
    • 10.5.1. Company overview
    • 10.5.2. Key executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
    • 10.5.6. Business performance
  • 10.6. Qiagen N.V
    • 10.6.1. Company overview
    • 10.6.2. Key executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance
    • 10.6.7. Key strategic moves and developments
  • 10.7. Becton, Dickinson and Company
    • 10.7.1. Company overview
    • 10.7.2. Key executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
    • 10.7.7. Key strategic moves and developments
  • 10.8. Seegene Inc
    • 10.8.1. Company overview
    • 10.8.2. Key executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
    • 10.8.6. Business performance
    • 10.8.7. Key strategic moves and developments
  • 10.9. MESO SCALE DIAGNOSTICS, LLC
    • 10.9.1. Company overview
    • 10.9.2. Key executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
  • 10.10. Diasorin S.p.A.
    • 10.10.1. Company overview
    • 10.10.2. Key executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Business performance
    • 10.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. MULTIPLEX ASSAY MARKET FOR PROTEIN BASED MULTIPLEX ASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. MULTIPLEX ASSAY MARKET FOR NUCLEIC ACID-BASED MULTIPLEX ASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. MULTIPLEX ASSAY MARKET FOR CELL-BASED MULTIPLEX ASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 06. MULTIPLEX ASSAY MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. MULTIPLEX ASSAY MARKET FOR INSTRUMENTS AND ACCESSORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. MULTIPLEX ASSAY MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 10. MULTIPLEX ASSAY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. MULTIPLEX ASSAY MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. MULTIPLEX ASSAY MARKET FOR COMPANION DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 14. MULTIPLEX ASSAY MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. MULTIPLEX ASSAY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. MULTIPLEX ASSAY MARKET FOR RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. MULTIPLEX ASSAY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. MULTIPLEX ASSAY MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 24. U.S. MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. U.S. MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 26. U.S. MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. U.S. MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. CANADA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 29. CANADA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 30. CANADA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. CANADA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 41. GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 42. GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. FRANCE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. FRANCE MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. UK MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. UK MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 51. UK MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. UK MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. ITALY MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. ITALY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 55. ITALY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 56. ITALY MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. SPAIN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. SPAIN MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. REST OF EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. REST OF EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. REST OF EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. REST OF EUROPE MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 67. ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 70. JAPAN MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 71. JAPAN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. JAPAN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. JAPAN MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. CHINA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. CHINA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 76. CHINA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. CHINA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. AUSTRALIA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 79. AUSTRALIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 80. AUSTRALIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. AUSTRALIA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. INDIA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 83. INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 84. INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 85. INDIA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH KOREA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH KOREA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH KOREA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 92. REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 93. REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 95. LAMEA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 96. LAMEA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 97. LAMEA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. LAMEA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 99. BRAZIL MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 100. BRAZIL MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 101. BRAZIL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 102. BRAZIL MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 103. SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 104. SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 105. SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 106. SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 107. SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 108. SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 109. SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 110. SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 111. REST OF LAMEA MULTIPLEX ASSAY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 112. REST OF LAMEA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 113. REST OF LAMEA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 114. REST OF LAMEA MULTIPLEX ASSAY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 115. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
  • TABLE 116. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
  • TABLE 117. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
  • TABLE 118. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
  • TABLE 119. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
  • TABLE 120. ILLUMINA INC.: KEY EXECUTIVES
  • TABLE 121. ILLUMINA INC.: COMPANY SNAPSHOT
  • TABLE 122. ILLUMINA INC.: PRODUCT SEGMENTS
  • TABLE 123. ILLUMINA INC.: PRODUCT PORTFOLIO
  • TABLE 124. RANDOX LABORATORIES LIMITED: KEY EXECUTIVES
  • TABLE 125. RANDOX LABORATORIES LIMITED: COMPANY SNAPSHOT
  • TABLE 126. RANDOX LABORATORIES LIMITED: PRODUCT SEGMENTS
  • TABLE 127. RANDOX LABORATORIES LIMITED: PRODUCT PORTFOLIO
  • TABLE 128. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
  • TABLE 129. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
  • TABLE 130. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
  • TABLE 131. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
  • TABLE 132. BIO-RAD LABORATORIES, INC. : KEY STRATERGIES
  • TABLE 133. ABCAM PLC.: KEY EXECUTIVES
  • TABLE 134. ABCAM PLC.: COMPANY SNAPSHOT
  • TABLE 135. ABCAM PLC.: PRODUCT SEGMENTS
  • TABLE 136. ABCAM PLC.: PRODUCT PORTFOLIO
  • TABLE 137. QIAGEN N.V: KEY EXECUTIVES
  • TABLE 138. QIAGEN N.V: COMPANY SNAPSHOT
  • TABLE 139. QIAGEN N.V: PRODUCT SEGMENTS
  • TABLE 140. QIAGEN N.V: PRODUCT PORTFOLIO
  • TABLE 141. QIAGEN N.V: KEY STRATERGIES
  • TABLE 142. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 143. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 144. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
  • TABLE 145. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 146. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
  • TABLE 147. SEEGENE INC: KEY EXECUTIVES
  • TABLE 148. SEEGENE INC: COMPANY SNAPSHOT
  • TABLE 149. SEEGENE INC: PRODUCT SEGMENTS
  • TABLE 150. SEEGENE INC: PRODUCT PORTFOLIO
  • TABLE 151. SEEGENE INC: KEY STRATERGIES
  • TABLE 152. MESO SCALE DIAGNOSTICS, LLC: KEY EXECUTIVES
  • TABLE 153. MESO SCALE DIAGNOSTICS, LLC: COMPANY SNAPSHOT
  • TABLE 154. MESO SCALE DIAGNOSTICS, LLC: PRODUCT SEGMENTS
  • TABLE 155. MESO SCALE DIAGNOSTICS, LLC: PRODUCT PORTFOLIO
  • TABLE 156. DIASORIN S.P.A.: KEY EXECUTIVES
  • TABLE 157. DIASORIN S.P.A.: COMPANY SNAPSHOT
  • TABLE 158. DIASORIN S.P.A.: PRODUCT SEGMENTS
  • TABLE 159. DIASORIN S.P.A.: PRODUCT PORTFOLIO
  • TABLE 160. DIASORIN S.P.A.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. MULTIPLEX ASSAY MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF MULTIPLEX ASSAY MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN MULTIPLEX ASSAY MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN MULTIPLEX ASSAY MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL MULTIPLEX ASSAY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. MULTIPLEX ASSAY MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR PROTEIN BASED MULTIPLEX ASSAYS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR NUCLEIC ACID-BASED MULTIPLEX ASSAYS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CELL-BASED MULTIPLEX ASSAYS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. MULTIPLEX ASSAY MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR INSTRUMENTS AND ACCESSORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. MULTIPLEX ASSAY MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR COMPANION DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. MULTIPLEX ASSAY MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CLINICAL LABORATORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 28. MULTIPLEX ASSAY MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 29. U.S. MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. CANADA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. MEXICO MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. GERMANY MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. FRANCE MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. UK MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. ITALY MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. SPAIN MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. REST OF EUROPE MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. JAPAN MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. CHINA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. AUSTRALIA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. INDIA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. SOUTH KOREA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. BRAZIL MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. SAUDI ARABIA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. SOUTH AFRICA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. REST OF LAMEA MULTIPLEX ASSAY MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49. COMPETITIVE DASHBOARD
  • FIGURE 50. COMPETITIVE HEATMAP: MULTIPLEX ASSAY MARKET
  • FIGURE 51. TOP PLAYER POSITIONING, 2022
  • FIGURE 52. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 53. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 54. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 55. ILLUMINA INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 56. ILLUMINA INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 57. ILLUMINA INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 58. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 60. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 61. ABCAM PLC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 62. ABCAM PLC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 63. QIAGEN N.V: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 64. QIAGEN N.V: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 65. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 66. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 67. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 68. SEEGENE INC: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 69. SEEGENE INC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 70. DIASORIN S.P.A.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 71. DIASORIN S.P.A.: REVENUE SHARE BY REGION, 2021 (%)